Penetration of Ravuconazole, a New Triazole Antifungal, into Rat Tissues

H. Mikamo, Xiang Yin, Yoh Hayasaki, +5

Chemotherapy

Fungal PathogensAntifungal AgentUterus TissueAntifungal AgentsMedicine +8

Comparative Study on the Effectiveness of Antifungal Agents in Different Regimens against Vaginal Candidiasis

Hiroshige Mikamo, Kyoko Kawazoe, Yasumasa Sato, +2

Chemotherapy

Vaginal microflora in healthy women with Gardnerella vaginalis

Hiroshige Mikamo, Yasumasa Sato, Yoh Hayasaki, +2

Journal of Infection and Chemotherapy

Vulvar DiseasesMicrobial DiseaseVaginal MicrofloraGynecologyVaginitis +3

Intravaginal bacterial flora in patients with uterine cervical cancer. High incidence of detection of Gardnerella vaginalis

Hiroshige Mikamo, Yasumasa Sato, Yoh Hayasaki, +5

Journal of Infection and Chemotherapy

Intravaginal Bacterial FloraGardnerella VaginalisVulvar DiseasesCervical CancerMicrobial Disease +9

MR imaging findings of uterine pyomyoma: radiologic–pathologic correlation

Hiromi Ono, Masayuki Kanematsu, Hiroki Kato, +5

Abdominal Imaging

Urogenital RadiologyMedical ImagingSurgical PathologyHistopathologyGynecology +5

Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study

Hirotoshi Iihara, Mototsugu Shimokawa, Yoh Hayasaki, +13

Gynecologic Oncology

Adequate Levofloxacin Treatment Schedules for Uterine Cervicitis Caused by <i>Chlamydia trachomatis</i>

Hiroshige Mikamo, Yasumasa Sato, Yoh Hayasaki, +2

Chemotherapy

High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the “SET” feature of high-grade serous carcinoma to the “STEM” feature

Yuichiro Hatano, Maho Tamada, Nami Asano, +4

Diagnostic Pathology

Effect of Ravuconazole, a New Triazole Antifungal, in a Rat Intraabdominal Abscess Model

Hiroshige Mikamo, Xiang Yin, Yoh Hayasaki, +2

Chemotherapy

Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials

Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, +14

BMC Cancer